000 03348nam a22002537a 4500
001 20241102125005.0
003 OCoLC
005 20241102125344.0
008 241102b |||||||| |||| 00| 0 eng d
020 _a978-3-031-64387-3
020 _a978-3-031-64388-0 (eBook)
040 _cddc
041 _aEnglish
100 _qZodwa Dlamini
222 _aabiraterone ADT advanced prostate cancer African Cancer Research androgen receptor antigen approaches autophagy biomarkers biopsy cancer cells cancer treatment castration-resistant prostate cancer Chair in Precision chemotherapy Chen Clinical Oncology clinical trials CRPC detection diagnosis disease Dlamini DNA docetaxel drugs enzalutamide erectile dysfunction European Urology factors Fig Fizazi G gene genetic genomic Gleason score H healthcare hormone therapy imaging immunotherapy improve inhibitors Integrative Journal of Clinical liquid biopsy metastatic metastatic castration-resistant prostate metastatic prostate cancer mHSPC minimally invasive molecular mutations Nuclear Medicine Oncology Research Unit outcomes pathways PC phase potential precision medicine Precision Oncology Research prostate cancer patients prostate-specific prostate-specific antigen protein PSA PSMA radiation therapy radical prostatectomy radiopharmaceuticals radiotherapy Research Institute PACRI response risk robotic robotic-assisted screening Sipuleucel-T South Africa South Africa e-mail specific surgeons surgery surgical survivorship T-cell targeted therapies techniques therapeutic tissue treatment options tumor University of Pretoria urinary Urology Wang Zhang
240 _aTransforming Prostate Cancer Care
243 _aTransforming Prostate Cancer Care
245 _aTransforming Prostate Cancer Care
_bAdvancing Cancer Treatment with Insights from Africa
260 _aPan African Cancer Research Institute University of Pretoria Pretoria, South Africa |
_b Springer Nature Switzerland AG |
_c 2024
300 _a308 Pages
520 _ausammenfassung: This book is an in-depth examination of the current state of the art and new advances in prostate cancer care and offers a fresh perspective with insights from Africa. At its core, the book tackles pivotal questions such as the mechanisms behind prostate cancer development, the significance of early detection, and how diagnostic advancements can lead to personalized treatment plans. It delves into genomic discoveries that are paving the way for targeted therapies and examines how immunotherapy is reshaping treatment paradigms. Furthermore, it explores surgical innovations and the role of radiopharmaceuticals in advancing prostate cancer management. The discussion extends to integrative care models that emphasize holistic patient well-being and strategies for enhancing survivorship. Unique about this book is that the authors provide insights from Africa into the prevalence and management of prostate cancer and place this in a global context. Aimed at healthcare professionals involved in oncology and prostate cancer research, including physicians, nurses and medical researchers, this book serves as an indispensable guide to the basic biological concepts of prostate cancer and its treatment in the clinic
856 _uhttps://doi.org/10.1007/978-3-031-64388-0
942 _2ddc
_cEB
_n0
999 _c29566
_d29566